Titan Pharmaceuticals (TTNP) has issued an announcement.
Titan Pharmaceuticals, Inc. has finalized a Settlement Agreement and General and Mutual Release with former directors Eric Greenberg, Matthew C. McMurdo, and David Natan following their resignations. This development marks a significant change in the company’s leadership dynamics and could be of interest to shareholders monitoring corporate governance and strategic direction shifts.
For a thorough assessment of TTNP stock, go to TipRanks’ Stock Analysis page.
